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Abstract
Pathogenicity of biosurfactant- producing microorganisms is currently 
raising some health, safety and environmental concerns. As a result, the 
industrial-scale production and application of biosurfactants as potential 
alternatives to the synthetic one is still an unachieved task. The production 
of biosurfactants using nonpathogenic/recombinant strains requires more 
attention and investigation for some advantages that includes the discov-
ery of non-toxic biosurfactants suitable for all industrial applications, 
identifying new biosurfactant congeners with better inherent surface-
active properties compared to that from pathogens and synthetic ones and 
the synthesis of biosurfactant without complex metabolic regulations. 
Although a number of nonpathogenic/recombinant, eco-friendly 
biosurfactant- producing strains have been documented, there is need for 
more research in this area focusing especially on improved biosurfactant 
production by these strains using optimisation processes and the discovery 
of new nonpathogenic/recombinant strain using molecular techniques for 
future sustainability.
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1  Introduction
Biosurfactants refer to surfactants from micro-
bial origin and can be synthesised by several 
identified microorganisms including bacteria, yeast 
and fungi. Originally, majority of the surfactants 
used in the industries today are petrochemical 
based, and these surfactants are not only par-
tially biodegradable but are also toxic to living 
organisms and have contributed to a wide range 
of environmental hazards. In addition, the pro-
duction of these petrochemical-based surfactants 
contributes to the depletion of the world’s 
non- renewable petrochemical resources. It has 
been reported that the worldwide production of 
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synthetic surfactants is over 15 million tons per 
year (Van-Bogaert et al. 2007) that are employed 
in different industrial sectors ranging from food 
processing, pharmaceutical, cosmetics, deter-
gent production, environmental cleanup (biore-
mediation) and enhanced oil recovery. According 
to Reznik et al. (2010), the worldwide produc-
tion of synthetic surfactants per annum was 13 
million tons in 2008, increased by 2 % in 2009 
resulting to annual turnover of US$ 2,433 billion. 
The market was then expected to experience a 
continuous growth by 28 % from 2009 to 2012 
and thereafter increase approximately by 3.5–4 %. 
However, biosurfactants have been reported by 
many researchers to have a variety of advantages 
over the petrochemical-based or synthetic sur-
factants. They display excellent surface activity 
and emulsification properties with very low 
toxicity and higher biodegradability features. 
They have also been found to be very effective at 
low concentrations and over a wide range of 
environmental conditions such as pH, temperature, 
salinity, alkalinity and acidity. Other important 
characteristics of these biomolecules include 
better environmental compatibility, lower critical 
micelle concentration, higher selectivity, specific 
activity and ability to be synthesised from renew-
able low- cost resources (Desai and Banat 1997; 
Oliveira et al. 2009; Rahman and Gakpe 2008).
These biosurfactants due to their amphiphilic 
properties have found potential application in an 
extremely wide variety of industrial process 
involving emulsification, foaming, detergency, 
wetting, dispersing or solubilisation. In addition, 
biosurfactants are currently being used as anti-
bacterial, antifungal, antiviral, antioxidant, mois-
turisers and antiradical and stabilising agents in 
the production of various industries, products 
ranging from cosmetics, food, pharmaceutical, 
agriculture and detergents. Their ability to stimu-
late dermal fibroblast metabolism and support 
healthy skin physiology has also put them on the 
front line as potential raw material for cosmetics 
such as deodorants, facial cosmetics, lotions, eye 
shadow, skin smoothing and anti-wrinkle and 
anti-ageing products (Rosenberg and Ron 1999; 
Banat et al. 2000; Rahman et al. 2002).
The commercial viability of biosurfactants as 
alternatives to the synthetic surfactants has been 
greatly hindered due to limiting technical and 
economic factors including high substrate cost 
(Mukherjee et al. 2006), low product yield 
(Maneerat 2005; Thavasi et al. 2011b), product 
mixtures resulting in high-cost downstream 
recovery/purification processes (Heyd et al. 
2008) and the type of producing strains (Reiling 
et al. 1986). Most biosurfactant-producing organ-
isms are pathogenic and difficult to handle in 
large-scale industrial processes (Gunther et al. 
2005; Toribio et al. 2010). In this review, after a 
discussion of the pathogenicity of biosurfactant, 
producers focus on the state of the art of production 
of biosurfactants from nonpathogenic eco- friendly 
organisms and on the heterologous production by 
recombinant strains.
2  Biosurfactant Production 
Using Pathogenic Organisms 
and Health and Safety Issues
The development of biosurfactant production in 
nonpathogenic organisms is a current challenge 
that is receiving increased attention in order to 
avoid pathogenicity and complex metabolic regu-
lations (Dusane et al. 2010) especially in rham-
nolipid synthesis by Pseudomonas aeruginosa 
and to screen for novel product spectra (Müller 
et al. 2012). Application of crude biosurfactants 
from pathogens in industrial and environmental 
applications is largely unacceptable especially in 
the cosmetics, health and food sectors due to 
the potential presence of toxins and pigments 
(Nicas and Iglewski 1985).
2.1  Rhamnolipids
Rhamnolipids are widely studied glycolipid 
 biosurfactants synthesised in large quantities 
by different strains of P. aeruginosa. As biosurfac-
tants, rhamnolipids play an important role for 
the producing organism, displaying useful 
 physico- chemical, physiological (Zhong et al. 2007) 
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and antimicrobial functions on other living systems 
(Bergstrom et al. 1946; Abalos et al. 2001). 
Excellent emulsifying properties relative to syn-
thetic surfactants make rhamnolipids viable alter-
natives due to their efficacy at low concentrations 
and their inherent biodegradability (Ron and 
Rosenberg 2002; Calvo et al. 2009; Rahman et al. 
2003), for example, the bioremediation of 
hydrocarbon- polluted sites (Thavasi et al. 2011a; 
Jorfi et al. 2013) and in enhanced oil recovery 
(Amani et al. 2013). However, the industrial- 
scale application of P. aeruginosa strains for 
rhamnolipid production is an unrealistic task: this 
organism is an opportunistic human pathogen 
(Rahman et al. 2010) and is responsible for infec-
tious diseases in immune-compromised individuals 
(Goethals et al. 2001). Addressing these safety 
issues renders that P. aeruginosa-derived biosur-
factant is uneconomical (Ochsner et al. 1995; 
Tuleva et al. 2002) and unsafe for industrial 
processes.
The cultivation of P. aeruginosa, a Gram- 
negative bacterium belonging to the taxonomi-
cal class of Gammaproteobacteria and the 
family Pseudomonadaceae, has been well stud-
ied, and the genome of strain PAO1 has been 
fully sequenced and annotated. The organism is 
found in various habitats including water, soil, 
plants and air, is resistant to a variety of antibi-
otics (Tummler et al. 1991) and is the main 
causative organism for cystic fibrosis and noso-
comial infections. The pathogenicity of P. aeru-
ginosa in cystic fibrosis was confirmed by 
Kownatzi et al. (1987) who discovered rhamno-
lipids of up to 8 μl/ml in the sputum of P. aeru-
ginosa-colonised cystic fibrosis patients. Read 
et al. (1992) also showed the presence of 65 μl/
ml rhamnolipid in the secretions of a lung 
removed from a cystic fibrosis patient. The cyto-
toxic and haemolytic effects of crude rhamno-
lipids from other rhamnolipid producers have 
been demonstrated by researchers (Häussler 
et al. 1998, 2003; Rahman et al. 2010). 
Rhamnolipids have been shown to be heat-sta-
ble haemolysins having haemolytic activity on 
various erythrocyte species (Fujita et al. 1998; 
Johnson and Boese-Marrazzo 1980) and 
 cytotoxic at high concentration to immune cells 
(Bjarnsholt et al. 2005; Jensen et al. 2007).
Rhamnolipids from P. aeruginosa stimulate 
the release of allergy and inflammatory media-
tors from the mast cells such as histamine, sero-
tonin and 12-hydroxyeicosatetraenoic acid 
(Bergmann et al. 1989; McClure and Schiller 
1992; König et al. 1992; Cosson et al. 2002; 
Andrä et al. 2006). Furthermore, rhamnolipids 
have been associated with several dysfunctions in 
the lungs and the entire respiratory tract. These 
include inhibition of ciliary function, damage to 
bronchial epithelium, alteration of respiratory 
epithelial ion movement and induction of the 
release of mucus conjugates from human bron-
chial mucosa, and very recently it has been 
reported that rhamnolipid synthesis is an impor-
tant prerequisite for the invasion of P. aeruginosa 
into human respiratory epithelial cells (Stutts 
et al. 1986; Graham et al. 1993; Fung et al. 1995; 
Zulianello et al. 2006). P. aeruginosa has been 
classified as biosafety level 2 organism due to the 
health and safety issues associated with the 
organism as well as the cytotoxic properties of 
their rhamnolipid species.
These safety concerns inhibit the economic 
viability of large-scale rhamnolipid production 
from P. aeruginosa. Such viability is further 
compromised by the involvement of complex 
quorum sensing and transcriptional mechanisms 
(Soberón-Chávez et al. 2005). Furthermore, the 
purification and treatment of the rhamnolipid 
yield from P. aeruginosa are also costly at the 
industrial scale, and it is important to note that 
rhamnolipids produced from P. aeruginosa fer-
mentation cannot be considered as safe raw mate-
rials in the production of food, pharmaceutical 
and cosmetics products. Thus there is need to 
explore for new nonpathogenic natural rhamno-
lipid producers. A survey of biosurfactants pro-
duced by pathogenic strains is presented in 
Table 1 together with their pathogenesis in 
humans, plants and animals.
Rhamnolipids are also produced by 
Burkholderia species; some of these organisms 
such as B. cepacia have been identified as human 
pathogens. This organism capable of producing a 
[AU1]
[AU2]
Production of Biosurfactants Using Eco-friendly Microorganisms
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
Table 1 Biosurfactant production by pathogenic bacterial strains
Biosurfactants Pathogenic producers Pathogenicity References
Rhamnolipids Pseudomonas 
aeruginosa
Cystic fibrosis, respiratory 
infections, multidrug resistant
Thavasi et al. (2011b),  
Jorfi et al. (2014), Kownatzi 
et al. (1987)
Burkholderia cepacia Lung infection, pneumonia St Denis et al. (2007), Yalçin 
and Ergene (2010)
Burkholderia 
pseudomallei
Melioidosis Andrea et al. (2008), Howe 
et al. (2006)
Burkholderia plantarii Fire blight disease of apple 
and pear trees
Hörmann et al. (2010), 
Mitchell and Teh (2005)
Burkholderia glumae Rot of rice grains and 
seedlings
Urakami et al. (1994), Costa 
et al. (2011)
Renibacterium 
salmoninarum
Bacterial kidney disease of 
salmonid fish
Christova et al. (2004), Wiens 
et al. (2008)
Glycolipids Pantoae agglomerans Bacteraemia, wound 
infection, arthritis, infection 
of soft tissues bones and 
joints in children
Vasileva-Tonkova and 
Geshava (2007), Jacobucci 
et al. (2009), Koo et al. (2006)
Nocardia 
otitidiscaviarum
Pulmonary nocardiosis, brain 
abscess, actinomycetoma
Vyas and Dave (2011), Pelaez 
et al. (2009), Chi et al. (2013)
Alcaligenes faecalis Post-operative 
endophthalmitis, peritonitis
Kaliaperumal et al. (2006), 
Kahveci et al. (2011),  
Bharali et al. (2011)
Trehalose mycolates Acinetobacter 
calcoaceticus IMV 
B-7241
Urinary tract infections, 
respiratory tract infections, 
post-operative infections
Pirog et al. (2013),  
Pal and Kale (1981)
Phospholipids Klebsiella pneumoniae Haemorrhage/necrosis, upper 
and lower respiratory tract 
infections, osteomyelitis, 
UTI, diarrhoea, wound 
infection, meningitis, 
bacteraemia, septicaemia, 
ankylosing spondylitis
Jamal et al. (2012), Rashid 
and Ebringer (2007), Ryan 
and Ray (2004), Limbago 
et al. (2012)
Lipopeptides Serratia marcescens Urinary tract infections, 
nosocomial bacteraemia, 
meningitis, endocarditis
Ibrahim et al. (2013), 
Anyanwu et al. (2010), 
Körner et al. (1994)
Inquilinus limosus 
KB3
Cystic fibrosis, multidrug- 
resistant lung infections
Saimmai et al. (2013), 
Wellinghausen et al. (2005), 
Hayes et al. (2009)
Heteropolysaccharides Cronobacter sakazakii Bacteraemia, meningitis, 
necrosis, enterocolitis, 
contamination of infant 
formula
Lai (2001), Jain et al. (2012), 
CDC (2002)
biosurfactant exhibiting a surface tension value 
of 45.7 mN m−1 (Yalçin and Ergene 2010) has been 
associated with lung infections and pneumonia in 
humans of all ages (St Denis et al. 2007). 
Similarly, B. pseudomallei, a biosurfactant producer 
(Howe et al. 2006), is a facultative intracellular 
pathogen, although the mechanism of its intracellu-
lar survival is yet unknown. This pathogen is the 
causative agent of melioidosis, an infectious disease 
endemic to Southeast Asia, northern Australia 
and tropical and subtropical regions (Andrea et al. 
2008). The di- rhamnolipids from B. pseudomallei 
have been found to exhibit serious cytotoxic 
effects on macrophages non- phagocytic and 
phagocytic cell lines (Sierra 1960; Kharazmi 
et al. 1989; Johnson and Boese- Marrazzo 1980; 
C. Uzoigwe et al.
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Fujita et al. 1988). Di-rhamnolipids have also 
been reported to be cytolytic to human mono-
cyte-derived macrophages and can inhibit the 
phagocytic response of macrophages even at low 
concentration.
Burkholderia plantarii DSM 9509 has been 
demonstrated to be the most prominent rhamno-
lipid producer. According to Hörmann et al. 
(2010) and Walter (2009), B. plantarii DSM 
9509 produced Rha2-C14-C14 congeners that 
reduced the surface tension of water to 29.4 mN 
m−1 with critical micelle concentrations (CMC) 
between 15 and 20 mg L−1. The maximum rham-
nolipid concentration during 0.5 L bioreactor cul-
tivation was 45.75 mg L−1. However, this 
organism is a plant pathogen responsible for the 
fire blight disease of apple and pear trees, and the 
di-rhamnolipid from B. plantarii is an endotoxin 
(Mitchell and Teh 2005). Costa et al. (2011) also 
showed rhamnolipid concentration of 1 g L−1 in 
B. glumae AU6208 at 34 °C, 2 % canola oil and 
100 mM urea, but this organism is toxic to rice 
grain and seedlings.
Renibacterium salmoninarum is a diplobacil-
lus fastidious bacterium identified as potent bio-
surfactant producer on n-hexadecane as a carbon 
source (Christova et al. 2004). It is also interest-
ing to know that this bacterium produces the two 
typical rhamnolipid as in P. aeruginosa and has 
the potential of being useful in natural degrada-
tion of hydrophobic pollutants due to its high cell 
hydrophobicity. Despite these promising charac-
teristics, this organism has raised a significant 
ecological concern. It causes a haemorrhagic 
infection known as bacterial kidney infection 
(BKD) or salmonid kidney disease in young sal-
monid fish (Wiens et al. 2008).
2.2  Glycolipids and Trehalose 
Mycolates
Glycolipid production by other known pathogens 
has been reported. The Antarctic facultative 
anaerobe Pantoea agglomerans is a biosurfactant 
producer with hydrocarbon compounds (hexane, 
kerosene and paraffin) as growth substrates 
(Vasileva-Tonkova and Gesheva 2007; Jacobucci 
et al. 2009). Pantoea sp. has also been reported as 
producers of high levels of exopolysaccharides 
with maximum production of 21 g L−1 in 24 h on 
glucose fructose and sucrose. However, Pantoea 
sp. have recently been consistently linked with 
infections in humans (wound, blood, soft tissue, 
bone and urinary tract infections) and plants (Da 
Baere et al. 2004; Fullerton et al. 2007; Kratz 
et al. 2003). These organisms have also been 
associated with bacteraemia outbreaks in many 
patients through their contact with contaminated 
cotton pledgets (Koo et al. 2006; Silvi et al. 2013).
Production of glycolipid biosurfactant has 
been reported for Nocardia otitidiscaviarum, a 
marine strain. The biosurfactant possessed 
increased cell hydrophobicity, making it very 
potent for bioremediation of oil-polluted sites 
(Vyas and Dave 2011). Recently, these bacterial 
species have been identified as causative agents 
in a couple of clinical infections ranging from 
pulmonary nocardiosis, brain abscess and actino-
mycetoma (Pelaez et al. 2009; Chi et al. 2013).
Alcaligenes faecalis has been reported by 
Bharali et al. (2011) as a producer of biosurfac-
tant exhibiting excellent surface activity using 
different hydrocarbon substrates. However, A. 
faecalis is a known pathogen infecting human 
and domesticated birds such as chickens and tur-
keys (Simmons et al. 1981). Kaliaperumal et al. 
(2006) reported A. faecalis as the causative agent 
in post-operative endophthalmitis in human eye 
resulting in symptoms such as swelling of the 
eyelid, redness and permanent loss of vision. 
In addition, Kahveci et al. (2011) have reported a 
link between the developments of peritonitis 
to contamination of catheters by A. faecalis. 
The pathogenic mechanism of this microbe is 
largely unknown.
Rosenberg et al. (1989) identified Acinetobacter 
calcoaceticus A2 as a producer of an extracellu-
lar anionic surfactant referred to as biodispersan 
or emulsan which is a high molecular weight bio-
surfactant. Pirog et al. (2009) have also reported 
the production of low molecular weight biosur-
factant by A. calcoaceticus IMV B-7241 which 
was confirmed to be trehalose mycolates by 
enzymatic studies. A. calcoaceticus has been 
described as a commensal in humans but is also 
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responsible for many clinical infections as an 
opportunistic pathogen. These infections include 
urinary tract infection, pneumonia, respiratory 
tract infection and post-operative infections 
(Pal and Kale 1981).
2.3  Phospholipids 
and Lipopeptides
Biosurfactant production by a prominent member 
of the Klebsiella genus known as Klebsiella 
pneumoniae has been identified. According to 
Jamal et al. (2012), Klebsiella pneumoniae 
WMF02 showed increased biosurfactant produc-
tion after medium optimisation with a maximum 
yield of 85 g L−1 and surface tension reduction of 
25.70 mN m−1 compared to the non-optimised 
medium (36.2 mN m−1). This organism has shown 
the promising potential of a good biosurfactant 
producer, but its application will involve certain 
health and safety risks. K. pneumoniae is a sig-
nificant human pathogen causing different 
destructive effects to the human upper and lower 
respiratory tracts if inhaled which includes pneu-
monia and bronchitis. Other notable infections 
caused by this organism include diarrhoea, 
wound infections, osteomyelitis, meningitis, bac-
teraemia and septicaemia (Ryan and Ray 2004). 
Recently, these bacterial strains have been 
reported as resistant to antibiotics especially car-
bapenem antibiotics (Limbago et al. 2012). They 
have also been associated with a chronic inflam-
matory spinal and large joint arthritic condition 
known as ankylosing spondylitis (AS) affecting 
young-aged males (Rashid and Ebringer 2007).
Serratia marcescens is a multidrug-resistant 
pathogen causing infections in different hosts 
ranging from plants, animals and humans. This 
bacterium produces a lipopeptide biosurfactant 
known as serrawettin (Dusane et al. 2011). The 
biosurfactant is very potent and has been reported 
in literature to reduce the surface tension of water 
from 72 to 37 mN m−1, emulsifying kerosene and 
diesel with a maximum emulsion index of 72 % 
and 40 %, respectively (Wei et al. 2004). Ferraz 
et al. (2002) also reported biosurfactant produc-
tion by S. marcescens strains. The biosurfactant 
reduced the surface tension of the culture medium 
from 64.54 to 29.57 mN m−1, while the crude bio-
surfactant reduced the surface tension of water 
from 72 to 28.70 mN m−1. However, this bacte-
rium cannot stand the chance of being used for 
industrial-scale production of biosurfactant due 
to its pathogenicity. Most importantly, serrawettin 
biosurfactant is a virulence factor, and S. marcescens 
strains have been linked with a of number 
infections including nosocomial infections bac-
teraemia, urinary tract infections, meningitis and 
endocarditis (Anyanwu et al. 2010; Körner et al. 
1994). According to a report by the Centers for 
Disease Control in the USA, S. marcescens was 
confirmed as the main causative organism in the 
Alabama hospital outbreaks that happened in 
2011 affecting 19 patients with 10 deaths.
Saimmai et al. (2013) identified a Gram- 
negative bacterium Inquilinus limosus KB3 
capable of producing lipopeptide biosurfactant 
using palm oil cake as a carbon source. The bio-
surfactant reduced the surface tension of water 
from 72 to 25.5 mN m−1 with a maximum yield 
of 5.13 g L−1 and CMC at 9 mg L−1. The genus 
Inquilinus was first defined in 2002 based on the 
molecular analysis of 51 unknown cystic fibrosis 
isolates. This group of organisms is unrelated to 
P. aeruginosa and B. cepacia. Inquilinus limosus 
has been reported as a multidrug-resistant pathogen 
and has been isolated from the lungs of cystic 
fibrosis patients (Wellinghausen et al. 2005; 
Hayes et al. 2009).
2.4  Heteropolysaccharides
Jain et al. (2012) reported the production of a het-
eropolysaccharide biosurfactant by an alkaliphi-
lic bacterium, Cronobacter sakazakii, formerly 
known as Enterobacter sakazakii. The biosurfac-
tant comprised of total sugars (733 %), reducing 
sugars (1,464 %), protein (119 %), uronic acid 
(1,598 %) and sulphate (6,015 %). The monosac-
charide moieties in this biosurfactant were 
revealed by GC-MS as glucose (14 %), mannose 
(24 %), galactose (14 %), xylose (20 %) and 
arabinose (19 %). The extracted biosurfactant 
from this bacterium efficiently emulsified aliphatic 
C. Uzoigwe et al.
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and aromatic hydrocarbons forming stable emul-
sions in the presence of xylene, cyclohexane, 
cyclooctane, toluene, carbon tetrachloride, 
dichloromethane, cottonseed, jojoba and ground-
nut oil at 1 mg mL−1. The inherent properties 
of the biosurfactant make it a potential candidate 
for bioremediation of oil and hydrocarbons. 
However, Cronobacter sakazakii is a Gram- 
negative pathogenic bacterium (Lai 2001), 
reported as the cause of meningitis bacteraemia, 
necrosis and enterocolitis in infants. Infections 
have been associated with the use of powdered 
infant formula contaminated with the bacterium 
(Bowen and Braden 2006; CDC 2002).
The industrial application of pathogenic bio-
surfactant producers is clearly problematic based 
on the pathogenic effects of the organisms and 
their products on humans and animals. 
Additionally, some of these pathogens exhibit 
multidrug resistance and have recorded high 
mortality rates from their associated diseases. 
Therefore, they are now considered as potential 
biological warfare agents and as such are not 
potential biological models for industrial bio-
technological processes (Walter 2009). For this 
combination of security and health reasons, there 
is a need to develop industrial processes based on 
nonpathogenic biosurfactant-producing strains.
3  Biosurfactant Production 
Using Nonpathogenic 
Organisms
Recently, due to the health and safety issues asso-
ciated with some biosurfactant-producing strains, 
research towards identifying new nonpathogenic 
producers and biotechnological production of 
biosurfactants using recombinant/mutant strains 
has been given more attention. The advantages 
of using nonpathogenic organisms may include 
production of biosurfactants with various con-
gener species, including the possibility of bio-
surfactants with less or no cytotoxic effects on 
living cells, and disconnection of their synthetic 
pathways from complex mechanisms such as 
quorum sensing in rhamnolipid synthesis. 
Nonpathogenic natural producer strains and their 
biosurfactant types identified to date have been 
reported (Table 2).
3.1  Rhamnolipids
Novel natural producers of rhamnolipids identi-
fied as P. clemancea nov. and P. teessidea nov. 
have been reported by Rahman et al. (2010). 
Rhamnolipid production can be achieved with 
Pseudomonas sp. other than P. aeruginosa. 
Pseudomonas fluorescens is a nonpathogenic 
Gram-negative, rod-shaped bacterium that has 
been found to produce biosurfactants as well as 
useful enzymes (cellulase, pectinase), self- 
defence factors (hydrogen cyanide), siderophores 
(pyochelin, pyoverdine), antibiotics (pyrrolnitrin, 
pyoluteorin) and 2,4-diacetylphloroglucinol, a 
molecule that can break down plant-derived car-
bohydrates, enhance host immune mechanisms 
and inhibit phytopathogens and bacteriophages 
(Stover et al. 2000; Paulsen et al. 2005). This 
organism has been reported as a degrader of cer-
tain environmental pollutants such as styrene, 
TNT and polycyclic aromatic hydrocarbons and 
as a result has been employed in many bioreme-
diation processes.
The production of a thermostable rhamnolipid 
biosurfactant with excellent foaming and emulsi-
fying stability by P. fluorescens was reported by 
Abouseoud et al. (2007). The biosurfactant was 
stable at 100 °C and retained its positive effect on 
surface tension (34–30 mN m−1) even at high pH 
values. Stoimenova et al. (2009) isolated from 
industrial wastewater P. fluorescens HW-6 capa-
ble of producing rhamnolipid biosurfactants at 
relatively high levels on various carbon substrates 
including hexadecane, vegetable oil, mineral oil 
and glycerol. The culture supernatant of the strain 
exhibited a reduction in surface tension to 
28.4 mN m−1. Vasileva-Tonkova et al. (2006) also 
reported production of rhamnolipid biosurfactant 
by P. fluorescens HW-6 at concentrations of 
14–20 g L−1 on hexadecane and interfacial  tension 
of 35 mN m−1, possessing a low critical micelle 
concentration value of 20 mg L−1. Recently, a 
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Table 2 Biosurfactant production using nonpathogenic bacteria
Biosurfactants Microbial strains
Physico-chemical 
characteristics References
Rhamnolipids Pseudomonas clemancea nov. Mesophilic Rahman et al. (2010)
Pseudomonas teessidea nov. Mesophilic Rahman et al. (2010)
Pseudomonas fluorescens Mesophilic Abouseoud et al. (2007), 
Vasileva-Tonkova  
et al. (2006)
Pseudomonas chlororaphis Mesophilic Gunther et al. (2005)
Pseudomonas putida BD2 Mesophilic Janek et al. (2013)
Burkholderia thailandensis Mesophilic Dubeau et al. (2009)
Enterobacter asburiae Mesophilic Hošaková et al. (2013)
Thermus aquaticus Thermophilic Řezanka et al. (2011)
Meiothermus ruber Thermophilic Řezanka et al. (2011)
Enterobacter hormaechei  
PTCC 1799
Mesophilic Rabiei et al. (2013)
Tetragenococcus koreensis Halophilic Lee et al. (2005)
Pseudoxanthomonas sp. PNK-04 Mesophilic Nayak et al. (2009)
Glycolipids Streptococcus thermophilus A Thermophilic Rodrigues et al. (2006a, b)
Lactococcus lactis  
53 L. acidophilus
Mesophilic Rodrigues et al. (2006a, b), 
Tahmourespour et al. (2011)
Lactobacillus coryniformis  
sp. torquens CECT 25600
Mesophilic Gudiña et al. (2011)
Lactobacillus paracasei  
sp. paracasei A20
Mesophilic Gudiña et al. (2011)
L. plantarum A14 Mesophilic Gudiña et al. (2011)
Leuconostoc mesenteroides Mesophilic Gudiña et al. (2011)
Lactobacillus delbrueckii Mesophilic Thavasi et al. (2011a)
Trehalose lipids Rhodococcus erythropolis IMV 
Ac-5017, Rhodococcus sp.
Mesophilic Pirog et al. (2013),  
Mutalik et al. (2008)
R. erythropolis ATCC 4277 Mesophilic Pacheco et al. (2010)
R. ruber Z25 Mesophilic Zheng et al. (2009)
Lipopeptides/phospholipids Bacillus subtilis DM-03,  
Bacillus subtilis DM-04
Mesophilic Das and Murkherjee (2007)
B. subtilis PT2 Mesophilic Pornsunthorntawee  
et al. (2008)
B. subtilis LB5a Mesophilic Nitschke and Pastore 
(2006)
B. subtilis Mesophilic Cooper et al. (1981)
B. lentus, B. firmus Mesophilic Ibrahim et al. (2013)
Bacillus licheniformis Biria et al. (2010)
Selenomonas ruminantium Mesophilic Saimmai et al. (2013)
Brevibacterium aureum MSA13 Mesophilic Kiran et al. (2010)
Corynebacterium kutscheri Mesophilic Thavasi et al. (2007)
Corynebacterium alkanolyticum 
ATCC 21511
Mesophilic Crosman et al. (2002)
Heteropolysaccharides Halomona sp. BS4 Halophilic Donio et al. (2013)
Halomonas sp. TG89 Halophilic Gutierrez et al. (2012)
Halomona eurihalina Halophilic Calvo et al. (2002)
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rhamnolipid exhibiting high  antimicrobial 
 activities on both Gram-positive and Gram-negative 
pathogenic strains – Listeria monocytogenes, 
Staphylococcus aureus, methicillin- resistant 
S. aureus, E. coli, Salmonella typhimurium and 
Candida albicans – has been reported to be pro-
duced from Pseudomonas fluorescens MFS03 
(Govindammal and Parthasarathi 2013). The bio-
surfactant was effective as a surface and emulsi-
fying agent and could have potential applications 
in the bioremediation of hydrocarbon-polluted 
sites. Rhamnolipid production was also reported 
for nonpathogenic P. chlororaphis (Gunther et al. 
2005) and P. putida BD2 (Janek et al. 2013).
Dubeau et al. (2009) reported production of 
0.4–1.5 g L−1 rhamnolipid by Burkholderia thai-
landensis at 34 °C with 4 % glycerol or canola oil 
in nutrient broth. B. thailandensis is a Gram- 
negative, mesophilic bacterium closely related to 
B. pseudomallei but rarely causes infections in 
humans or animals (Wuthiekanun et al. 1996; 
Smith et al. 1997; Lertpatanasuwan et al. 1999). 
The lethal inoculum size for B. thailandensis is 
approximately 1,000 times higher than that for B. 
pseudomallei (Joost Wiersinga et al. 2008). This 
organism does not require biosafety level 3 con-
ditions and has no restriction on the use of antibi-
otics or resistance markers for its genetic 
manipulation. The organism is not considered as 
a biosecurity threat and therefore is a potential 
industrial tool (Haraga et al. 2008; Glass et al. 
2006). Recently, Hošaková et al. (2013) identi-
fied Enterobacter asburiae as nonpathogenic 
rhamnolipid producers. Rezanka et al. (2011) 
reported on three novel rhamnolipid-producing 
organisms and were identified as Thermus sp., 
Thermus aquaticus and Meiothermus ruber. 
These organisms have been categorised as bio-
safety level 1 organisms and are not pathogenic 
to humans. Pantazaki et al. (2010) have reported 
the simultaneous production of polyhydroxyal-
kanoates (PHAs) and rhamnolipids by a non-
pathogenic thermophilic bacterium Thermus 
thermophilus HB8 (DSM 579) cultivated in min-
eral salt medium at 75 °C using glucose and 
sodium gluconate as sole carbon sources. Other 
new nonpathogenic rhamnolipid producers 
include Enterobacter hormaechei PTCC 1799 
(Rabiei et al. 2013), Tetragenococcus koreensis 
(Lee et al. 2005) and Pseudoxanthomonas sp. 
(Nayak et al. 2009).
3.2  Glycolipids
The Streptococcus thermophilus bacterium is 
used widely in the dairy industries for the produc-
tion of yogurt and cheese and is considered as 
beneficial to health since it aids digestion of dairy 
products in lactose-intolerant individuals (Kiliç 
et al. 1996; Hutkins 2002; Taylor and Mitchell 
2007). According to Busscher et al. (1997), a bio-
surfactant released from S. thermophilus was used 
in the control of fouling of heat-exchanger plates 
in pasteurisers because it inhibited the colonisa-
tion of other thermophilic and pathogenic strains 
of Streptococcus responsible for fouling. Two 
probiotic bacteria Lactococcus lactis 53 and 
S. thermophilus A have been identified as produc-
ers of cell-bound biosurfactants at the stationary 
growth phase in the presence of lactose and cheese 
whey as carbon substrates (Rodrigues et al. 2006a, 
b). A protein-containing biosurfactant from 
Lactobacillus acidophilus has also been demon-
strated to reduce the adhesion and biofilm forma-
tion of Streptococcus mutans on glass slides 
(Tahmourespour et al. 2011), indicating that the 
treatment of teeth with this biosurfactant may be 
an alternative dental control for biofilm develop-
ment and adhesion of the pathogens on teeth.
Similarly, Gudiña et al. (2011) investigated 
the production of cell-bound and excreted biosur-
factant by three lactobacilli strains and 
Leuconostoc mesenteroides strains. The lactoba-
cilli strains were L. coryniformis sp. torquens 
CECT 25600, L. paracasei sp. paracasei A20 
and L. plantarum A14. The studies revealed a 
decrease in surface tension of the culture broth 
for all the strains after 72 h incubation and the 
surface tension ranged from 1.4 to 6.4 mN m−1. 
The highest excreted biosurfactant rate was 
recorded for L. paracasei sp. paracasei A20 with 
surface tension of 6.4 mN m−1. However, the level 
of cell-bound biosurfactant was found to be 
higher than that of excreted molecules for all the 
strains. This is in contrast to other microorganisms 
[AU3]
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such as Pseudomonas and Bacillus that primarily 
excrete biosurfactant into their medium. 
Biosurfactant production has also been reported 
for nonpathogenic L. delbrueckii by Thavasi 
et al. (2011a). This organism showed maximum 
glycolipid production of 5.35 mg L−1 at 144 h 
incubation with peanut oil cake as substrate, but 
higher production was recorded after the station-
ary phase of growth. This was thought to be due 
to the release of cell-bound biosurfactant in the 
early stationary phase. In addition, L. delbrueckii 
could maximally degrade 61.25 % crude oil in 
the presence of fertilisers; hence the organism is 
both a biosurfactant producer and a hydrocarbon 
degrader. Lactobacilli are probiotics and non-
pathogenic organisms designated “Generally 
Recognized as Safe” (GRAS) by the American 
Food and Drug Administration (FDA). The 
organism’s ability to utilise lactose instead of 
glucose via an alternative metabolic pathway for 
biosurfactant synthesis has proven them as ideal 
hosts for biotechnological techniques especially 
metabolic engineering towards large-scale pro-
duction of cell-bound biosurfactants (Rodrigues 
et al. 2006a, b). Although the biosurfactant yield 
by these organisms is low, optimisation of culture 
conditions may improve their production.
Rhodococcus sp. are a group of aerobic, non- 
sporulating, Gram-positive bacteria that can be 
found in a wide range of environments. They are 
usually considered as experimentally advanta-
geous due to their high growth rate and simple 
developmental cycle. These organisms are 
effective for the degradation of aromatic hydro-
carbons, production of bioactive steroids, 
 bio-desulphurisation of fossil fuel and biocon-
version of waste products to valuable com-
pounds (McLeod and Eltis 2008). Strains of 
these species have been reported as biosurfac-
tant producers including R. erythropolis IMV 
Ac-5017 (Pirog et al. 2013) and Rhodococcus 
sp. MTCC 2574 (Mutalik et al. 2008). 
Furthermore, Pacheco et al. (2010) have identi-
fied Rhodococcus erythropolis ATCC 4277 is a 
producer of a biosurfactant exhibiting excellent 
enhanced oil desorption from an oil shale. 
Rhodococcus ruber Z25 identified by 16 rDNA 
sequencing produced cell growth-associated 
biosurfactants on n- hexadecane with maximum 
yield of 13.34 g L−1 at 44 h (Zheng et al. 2009). 
Rhodococcus spp. produce surface-active treha-
lose lipids, and reports have shown that these 
surface-active compounds present interesting 
physico-chemical and biological properties. 
Trehalose lipids can significantly reduce the 
surface tension of water from 70 mN m−1 to 
30.8 mN m−1 (Mutalik et al. 2008) and can form 
microemulsions (Zaragoza et al. 2013). In addi-
tion, trehalose lipids have been reported to 
inhibit protein kinase activity in vivo (Isoda 
et al. 1997) and induce the cell lysis of E. coli 
IEM-1 as well as the vegetative and spore cells 
of Bacillus subtilis BT-2 (Pirog et al. 2013). 
They have also been found useful in soil biore-
mediation and microbial enhanced oil recovery 
(Philip et al. 2002; Bell et al. 1998). This group 
of bacteria is considered as an ideal host for bio-
technological production of non-toxic biosur-
factant on industrial scales because of their 
genetic and catabolic diversity (associated pre-
sumably with their large chromosome and three 
large linear plasmids (van der Geize and 
Dijkhuizen 2004; McLeod et al. 2006). These 
organisms are usually nonpathogenic with only 
two species R. fascians and R. equi (Goethals 
et al. 2001) identified as plant and animal patho-
gens as well as causing infections in immune- 
compromised individuals. Nonpathogenic 
biosurfactant producers and their biosurfactants 
are shown in Table 1.2.
3.3  Lipopeptides 
and Phospholipids
Biosurfactants other than glycolipids produced 
by nonpathogenic organisms have been docu-
mented in literature. Bacillus subtilis is a ubiqui-
tous Gram-positive rod-shaped bacterium, found 
commonly in water, soil and air, and contributes 
to nutrient cycling in the environment. This 
organism is industrially useful as it is one of the 
most widely used bacteria in the production of 
enzymes (amylases, proteases, inosine, ribosides 
and amino acids) and speciality chemicals including 
biosurfactants (Erikson 1976). This bacterium 
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has also been shown to produce a variety of 
antibacterial (Katz and Demain 1977) and 
antifungal (Korzybski et al. 1978) compounds 
including difficidin and oxydifficidin with wide 
spectrum of antibiotic activities against aerobic 
and anaerobic bacteria (Zimmerman et al. 1987). 
It has been used as a fungicide because it has the 
inherent ability to colonise root systems and to 
inhibit the growth of fungal plant pathogens 
(Kimura and Hirano 1988; Loeffler et al. 1986). 
Although B. subtilis has been associated with 
outbreaks of food poisoning (Gilbert et al. 1981; 
Kramer et al. 1982) and human infections espe-
cially in hospitalised patients with surgical 
wounds, breast cancer and leukaemia (Logan 1988), 
the exact nature of its involvement in infections 
has not been established. However, a literature 
review by Edberg (1991) revealed that B. subtilis 
does not produce significant quantities of extra-
cellular enzymes or virulence factors that would 
predispose it to cause infection. In addition, Ihde 
and Armstrong (1973) reported that B. subtilis is 
an organism with low virulence. The organism 
has therefore been classified as neither a human 
(Edberg 1991) nor plant (Claus and Berkeley 1986) 
pathogen. According to the National Institutes of 
Health (NIH) guidelines for research involving 
recombinant DNA molecules (US Department 
of Health and Human Services 1986) and the 
European Federation of Biotechnology guidelines, 
B. subtilis is considered a class 1 containment 
agent, and their industrial use in fermentation 
processes presents low risk of adverse effects to 
human health and  environment. Bacillus subtilis 
produces an effective and active cyclic lipopeptide 
biosurfactant known as surfactin (Cooper et al. 
1987; Peypoux et al. 1999). Das and Mukherjee 
(2007) reported the production of lipopeptide 
surfactants by two strains Bacillus subtilis 
DM-03 and Bacillus subtilis DM-04 on potato 
peels using both submerged and solid-state 
fermentation techniques. Production of biosur-
factant with enhanced surface tension reduction 
of 26 mN m−1 and lower CMC of about 25 mg L−1 
has been reported for B. subtilis PT2 strain 
(Pornsunthorntawee et al. 2008). Similarly, B. 
subtilis LB5a decreased surface tension to a 
minimum value of 26.6 mN m−1 with CMC of 
33 mg L−1 (Nitschke and Pastore 2006). Cooper 
et al. (1981) had earlier reported production of 
lipopeptide biosurfactants by B. subtilis strains 
with a minimum surface tension of 25 mN m−1 
and a CMC of 25 mg L−1. Surfactin has been 
demonstrated as one of most effective biosur-
factants because of its high surface activity, effi-
ciency in bioremediation and in situ microbial 
enhanced oil recovery (Mulligan 2005; Awashti 
et al. 1999; Besson and Michel 1992). Therefore, 
the production of biosurfactants from B. subtilis 
has the potential for large-scale bio-industrial 
development. Nonpathogenic lipopeptide- 
producing bacteria identified as Bacillus lentus 
and B. firmus have also been reported by Ibrahim 
et al. (2013) and Joshi et al. (2013).
Bacillus licheniformis is an important pro-
ducer of lipopeptide biosurfactants (Biria et al. 
2010) and has been used in industrial  fermentation 
processes for over a decade for the production of 
several enzymes, antibiotics and special chemi-
cals (Gherna et al. 1989; Eveleigh 1981). 
Although these Bacillus species have been 
reported to be associated with human infections, 
these occurred only in immunosuppressed indi-
viduals following trauma and other predisposing 
factors. Therefore, according to the Biotechnology 
Program under the Toxic Substances Control Act 
under the US EPA (1997), B. licheniformis is 
classified as a nonpathogen and is not toxigenic. 
Furthermore, the National Institutes of Health 
and European Federation of Biotechnology 
guidelines have also placed this organism as a 
class 1 containment agent (Frommer et al. 1989). 
Nonpathogens other than Bacillus sp. such as 
Selenomonas ruminantium (Saimmai et al. 2013) 
and Brevibacterium aureum MSA13 (Kiran et al. 
2010) have also been identified for the produc-
tion of lipopeptide biosurfactants.
Corynebacterium sp. is Gram-negative, 
catalase- positive, rod-shaped facultative anaero-
bic bacterium. Most members of this genus are 
nonpathogenic and industrially useful as they are 
known for the synthesis of amino acids, nucleo-
tides and enzymes, for the bioconversion of steroids 
and for the degradation of hydrocarbons and are 
used in cheese ageing (Seidel et al. 2007; Natsch 
et al. 2005). The production of glycolipopeptide and 
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phospholipid biosurfactants has been reported for 
two nonpathogenic species such as C. kutscheri 
and C. alkanolyticum ATCC 21511, respectively 
(Thavasi et al. 2007; Crosman et al. 2002).
3.4  Heteropolysaccharides
Halomonas are a group of Gram-negative, non- 
sporing bacteria usually found in many different 
extreme water and soil environments, mainly 
saline, hypersaline or alkaline ecosystems. They 
belong to the family of Halomonadaceae and 
are classified as Gammaproteobacteria currently 
made up of 10 genera. They are considered to be 
nonpathogenic (von Graevenitz et al. 2000) and 
are potential industrial microbes due to their abil-
ity to synthesise microbial exopolysaccharides. 
Levan and mauran are examples of microbial 
polysaccharides from Halomonas spp. with a 
considerable market due to their exceptional per-
formance at extreme industrial conditions (Poli 
et al. 2009; Llamas et al. 2006.) Although a few 
strains have been associated with certain human 
infections and contamination in a dialysis centre 
(Stevens et al. 2009), several Halomonas species 
have been classified as nonpathogens and also 
identified as biosurfactant producers. According 
to Donio et al. (2013), Halomonas sp. BS4 iso-
lated from solar salt works has produced a het-
eropolysaccharide biosurfactant that suppressed 
the proliferation of mammary epithelial carci-
noma cells by 46.77 % at 25 μL concentration. In 
addition, the pure biosurfactant exhibited 
 antibacterial activity on Staphylococcus aureus, 
Klebsiella pneumoniae, Streptococcus pyogenes 
and Salmonella typhi and antifungal activity on 
Aspergillus niger, Fusarium sp., Aspergillus 
 flavus and Trichophyton rubrum. The biosurfac-
tant was also found to display antiviral activity on 
white spot syndrome virus at high percentage 
(60, 80 and 100 %) and effectively suppressed the 
pathological effect of the virus. Gutierrez et al. 
(2013) have also shown the significance of 
 exopolysaccharide (EPS) produced from marine 
Halomonas sp. TG89 in trace metal biogeochemical 
cycling. Calvo et al. (2002) have also documented 
the production of EPS from Halomona eurihalina. 
This research revealed that EPS from Halomonas 
contained high levels of K, Ca, Mg and several 
trace metals such as Zn, Cu, Fe and metalloid Si 
and has the specific ability to bind Ca, Si, Fe, Mn, 
Mg and Al in marine sediments. Furthermore, the 
growth of marine diatom Thalassiosira weissflogii 
was enhanced in the presence of purified EPS or 
to marine sediments exposed to EPS, indicating 
that the trace metals bound to the EPS become 
biologically available for the diatoms to utilise for 
growth. This bacterium therefore has the poten-
tial for the biotechnological development of safe 
antimicrobial and anticancer drugs as well as 
eco-friendly environmental products.
4  Production of Biosurfactant 
by Recombinant Strains
Pathogenicity may be avoided by the expression 
of biosurfactant production in heterologous 
microbial strains and mutants. Rhamnolipids can 
be synthesised by nonpathogenic heterologous 
strains provided with the rhamnosyltransferase 
genes rhlA, rhlB and rhlC. According to Cha 
et al. (2008), nonpathogenic heterologous P. 
putida 1067 (pNE2) expressing the rhlABRI gene 
from pathogenic P. aeruginosa EMS1 cultured in 
the mineral salt medium for 7 days in the pres-
ence of 2 % soybean oil as the sole carbon source 
exhibited rhamnolipid productivity that was 
greater than that of P aeruginosa EMS1. Scope 
remains for optimisation of the production condi-
tions potentially leading to increased biosurfac-
tant production making this organism useful for 
industrial biosurfactant production. Furthermore, 
Ochsner et al. (1995) investigated the heterologous 
expression of rhlAB in P. fluorescens, P. putida 
and E. coli. The results showed 0.25 g L−1, 0.6 g 
L−1 and no rhamnolipid, respectively, for the 
organisms, but Wang et al. (2007) have reported 
rhamnolipid production in E. coli BL21 with the 
expression of rhlAB operon (Table 3).
In another study, rmlBDAC operon involved in 
dTDP-l-rhamnose biosynthesis was introduced 
into E. coli W3110 in addition to rhlAB operon, 
and a total final concentration of 120.6 mg L−1 
mono-rhamnolipid was achieved using glucose as 
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carbon substrate (Cabrera-Valladares et al. 2006). 
Similarly, recombinant E. coli HB101 was also 
detected to produce 52 mg L−1 rhamnolipid with 
oleic acid as substrate (Cabrera-Valladares et al. 
2006). A successful development of a non-
pathogenic host capable of producing mono- 
rhamnolipids using glucose as substrate has been 
reported by Wittgens et al. (2011). In this study, 
the synthesis of mono-rhamnolipid independent 
from biomass formation was done using P. putida 
KT2440 expressing the rhlAB genes from P. 
aeruginosa PA01. A sevenfold increase in the 
final rhamnolipid concentration from 0.22 to 
1.5 g L−1 was recorded after genetic optimisation 
of the strain. The engineered strain exhibited 
some advantages compared to rhamnolipid pro-
duction in P. aeruginosa. Firstly, these strains are 
nonpathogenic and can appropriately substitute the 
opportunistic pathogenic P. aeruginosa. Secondly, 
rhamnolipid production in the recombinant 
strains was void of the complex quorum sensing 
regulation. However, the production rate in the 
recombinant strain was about two thirds of that 
usually obtained in optimised fermentation with 
P. aeruginosa although there remains the possibility 
of increasing the production rate by increasing the 
availability of activated rhamnose in the medium. 
More importantly, compared to P. aeruginosa, it 
is the utilisation by the recombinant strains of 
glucose instead of hydrophobic substances. 
Glucose as a carbon substrate is relatively cheap 
and is applied in many biotechnological processes 
(Blank et al. 2008). Furthermore, these recombinant 
strains capable of substituting P. aeruginosa can 
utilise hydrophilic substances, reaching a maximum 
rhamnolipid concentration in medium after 
1–2 days. This is compared with the wild-type 
strain of P. aeruginosa PA01 that although it 
exhibits higher rhamnolipid production, it 
requires 1–3 days to reach their maximal levels. 
This reduction in process time exhibited by 
recombinant strains enhances the space-time 
yield for the process (Wittgens et al. 2011). 
According to this investigation, the engineered 
P. putida KT2440 is the second recombinant 
strain featuring the highest recorded space, time, 
and yield, therefore making this strain a potential 
industrial tool for biotechnological rhamnolipid 
synthesis.
Burkholderia kururiensis KP23(T), a 
trichloroethylene- degrading, nitrogen-fixing and 
plant growth-promoting bacterium, has been 
reported to produce rhamnolipids, and when 
genetically engineered with two biosynthetic 
enzymes from P. aeruginosa RhlA and RhlB, 
rhamnolipid production increased by sixfold 
compared to wild-type strain. Rhamnolipids pro-
duced by the engineered strains were mainly 
mono-RL as opposed to wild-type strains B. 
kururiensis and P. aeruginosa that predominantly 
produce di-RLs. This organism is a promising 
biosurfactant producer with potential environ-
mental and biotechnological application espe-
cially due to its nonpathogenicity and 
compatibility with metabolic engineering proce-
dures (Tavares et al. 2013).
5  Conclusion
The development of biosurfactant production in 
nonpathogenic organisms is a current challenge 
that is receiving increased attention in order to 
avoid pathogenicity and complex metabolic regu-
lations. Most biosurfactant-producing organisms 
are pathogenic and difficult to handle in large- 
scale industrial processes. Pathogenicity of bio-
surfactant producers is key factor to prevent 
large-scale production; therefore, the nonpathogenic 
eco-friendly organisms need to be explored further, 
and a library of collections is important for the 
future development in this area of study.
[AU4]
Table 3 Recombinant biosurfactant producers
Biosurfactants Microbial strains References
Rhamnolipids Pseudomonas putida 
1067(PNE2)
Cha et al. 
(2008)
Pseudomonas 
fluorescens
Ochsner 
et al. (1995)
E. coli W3110, E. coli 
HB101
Cabrera- 
Valladares 
et al. (2006)
P. putida KT2440 Wittgens 
et al. (2011)
Burkholderia 
kururiensis KP23(T)
Tavares 
et al. (2013)
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